Send InquiryMenactra Meningococcal Polysaccharide Vaccine
Menactra Meningococcal Polysaccharide Vaccine Specification
- Dosage
- Single dose of 0.5 ml via intramuscular injection
- Storage Instructions
- Store at 2C to 8C; do not freeze
- Indication
- For individuals at risk of invasive meningococcal disease
- Formulations Type
- Injection
- Product Type
- Meningococcal Polysaccharide Vaccine
- Treatments & Functions
- Active immunization against meningococcal diseases
- Suitable For
- Children (2 years and above), adolescents, adults up to 55 years
- Age Group
- 2 years to 55 years
- Volume
- 0.5 ml per dose
- Shelf Life
- 24 months
- Contraindications
- Previous severe allergic reaction to any component of the vaccine or to a previous dose
- Regulatory Status
- WHO prequalified, licensed in multiple countries
- Common Side Effects
- Pain at injection site, redness, swelling, headache, malaise, fever
- Route of Administration
- Intramuscular
- Prescription Status
- Prescription Only Medicine (POM)
About Menactra Meningococcal Polysaccharide Vaccine
Menactra meningococcal polysaccharide vaccine
Meningococcal vaccine is a vaccine used against Neisseria meningitidis, a bacterium that causes meningitis, meningococcemia, septicemia, and rarely carditis, septic arthritis, or pneumonia. Mencevax (GlaxoSmithKline) and NmVac4-A/C/Y/W-135 (JN-International Medical Corporation) are used worldwide, but have not been licensed in the United States.
The first meningococcal conjugate vaccine (MCV4), Menactra, was licensed in the U.S. in 2005 by Sanofi Pasteur; Menveo, was licensed in 2010 by Novartis. Both MCV4 vaccines have been approved by the Food and Drug Administration (FDA) for people 2 through 55 years of age. In April 2011, Menactra received FDA approval for use in children as young as 9 months, although the Centers for Disease Control and Prevention (CDC) has not made recommendations for or against its use in children less than 2 years.
Comprehensive Protection Against Meningococcal Disease
Menactra provides robust and proven immunization against invasive meningococcal infections. Especially recommended for children, adolescents, and adults up to 55 years, this single-dose vaccine offers peace of mind for those at elevated risk, including travelers and students.
Safety and Regulatory Assurance
With WHO prequalification and licensing in numerous countries, Menactra meets stringent international safety and efficacy standards. It is available in India via authorized suppliers, wholesalers, and distributors, ensuring access to quality-assured healthcare solutions.
Simple Storage and Administration
Menactra comes in a ready-to-use 0.5 ml injectable formulation for intramuscular administration. The vaccine retains its stability for 24 months when stored at 2C to 8C, simplifying logistics for healthcare providers and ensuring vaccine potency.
FAQs of Menactra Meningococcal Polysaccharide Vaccine:
Q: How is Menactra vaccine administered?
A: Menactra is given as a single 0.5 ml dose via intramuscular injection, typically administered by a healthcare professional into the muscle of the upper arm or thigh.Q: What is the recommended age group for receiving Menactra?
A: Menactra is suitable for children from 2 years of age, adolescents, and adults up to 55 years old who are at risk of meningococcal disease.Q: What are the common side effects after receiving Menactra?
A: Common side effects include pain, redness, or swelling at the injection site, as well as headache, general malaise, and fever. These are usually mild and short-lived.Q: When is Menactra contraindicated?
A: Menactra should not be used in individuals who have experienced a severe allergic reaction to any component of this vaccine or to a prior dose.Q: What are the storage requirements for Menactra vaccine?
A: Menactra should be stored refrigerated between 2C and 8C. It must not be frozen to maintain its effectiveness.Q: Where can Menactra vaccine be sourced in India?
A: Menactra is available through authorized dealers, distributors, exporters, suppliers, traders, and wholesalers across India, ensuring widespread and regulated access.Q: What benefits does Menactra offer?
A: Menactra provides active immunization against invasive meningococcal diseases, reducing the risk of severe illness in individuals at increased exposure risk.
Get Latest Price
Price:
- 50
- 100
- 200
- 250
- 500
- 1000+
More Products in Vaccine And Injections Category
HUCOG Injection
Price 45 INR / Piece
Minimum Order Quantity : as per requirement Piece
Suitable For : Other, Men and Women
Treatments & Functions : Other, Female infertility, Ovulation induction, Male hypogonadism, Cryptorchidism
Use : Other Uses, Clinical, Hospital, Personal, Commercial
Feature : Other , Highly purified, Ready to use, Effective dosage
Docenat Injection
Price 9000 INR / Box
Minimum Order Quantity : as per requirement Box
Suitable For : Other, Oncology/Anti Cancer Use
Treatments & Functions : Other, Anti Cancer
Use : Other Uses, Hospital, Clinic, Personal
Feature : Other , High efficacy, reliable formulation, GMP certified
Zoldria Injection
Suitable For : Other, Adults
Treatments & Functions : Other, Used to treat high blood calcium levels (hypercalcemia) that may occur with cancer, and to strengthen bones in certain types of cancer patients
Use : Other Uses, Hospital, Clinical, Personal
Feature : Other , Lyophilized powder, ready to reconstitute and inject, singledose vial
Forteo Injection
Suitable For : Other, Individuals with osteoporosis particularly postmenopausal women and men at high risk for fractures
Treatments & Functions : Other, Stimulates bone formation and increases bone density
Use : Other Uses, Daily subcutaneous injection as prescribed by a healthcare provider
Feature : Arthritic Effects
&
We are accepting bulk order quantity.
Developed and Managed by Infocom Network Private Limited.
